LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 14

Search options

  1. Article ; Online: Enhancing medical student diversity through a premedical program: A Caribbean school case study.

    DeCarvalho, Helena / Lindner, Inna / Sengupta, Anamika / Rajput, Vijay / Raskin, Gannady

    Education for health (Abingdon, England)

    2018  Volume 31, Issue 1, Page(s) 48–51

    Abstract: Background: Physicians with backgrounds underrepresented in medicine (URiM) are more likely to practice in underserved communities. Recruitment into and assistance during medical education has the potential to increase the number of URiM physicians. ... ...

    Abstract Background: Physicians with backgrounds underrepresented in medicine (URiM) are more likely to practice in underserved communities. Recruitment into and assistance during medical education has the potential to increase the number of URiM physicians. This study analyzes URiM students' academic performance at a well-established Caribbean school with and without prior successful completion of the Medical Education Readiness Program (MERP).
    Methods: A retrospective analysis of premedical school requirements and achievements in medical school were performed for URiM students enrolled in Ross University School of Medicine between 2006 and 2012, through either MERP or direct admission. For MERP and non-MERP students, an independent sample two-tailed Student t-test was used to compare prerequisite Grade Point Average (p GPA), Medical College Admission Test (MCAT), and The United States Medical Licensing Examination (USMLE) Step 1 scores. Chi-square analysis was performed to compare the attrition rates for MERP and non-MERP URiM students in the first years of medical schools well as USMLE Step 1 pass rates.
    Results: A total of 1299 students entering medical school directly (n = 981) or through MERP (n = 318) were evaluated. The mean MCAT (19.6 for MERP vs. 21.6 for non-MERP, P < 0.001) and prerequisite GPA (2.8 for MERP vs. 3.1 for non-MERP, P < 0.001) were significantly lower for the MERP students. A similar percentage of MERP and non-MERP students reached the 2
    Discussion: MERP-like programs can help URiM students with lower undergraduate scores succeed in medical school.
    MeSH term(s) African Americans/education ; Caribbean Region ; Education, Medical/methods ; Hispanic Americans/education ; Humans ; Indians, North American/education ; Minority Groups/education ; Retrospective Studies ; Students, Medical ; United States
    Language English
    Publishing date 2018-08-17
    Publishing country India
    Document type Journal Article
    ZDB-ID 1318454-4
    ISSN 1469-5804 ; 1357-6283
    ISSN (online) 1469-5804
    ISSN 1357-6283
    DOI 10.4103/1357-6283.239047
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: 6,7-dihydroxy-3,4-dihydroisoquinoline: a novel inhibitor of nuclear factor-kappaB and in vitro invasion in murine mammary cancer cells.

    Alvarez, Francisco N / Carlson, Louise M / Lindner, Inna / Lee, Kelvin P

    Chemotherapy

    2009  Volume 55, Issue 3, Page(s) 175–182

    Abstract: Background: The inhibition of nuclear factor (NF)-kappaB with nontoxic agents is a promising possible treatment approach that may inhibit tumor cell proliferation, counteract the prosurvival pathways that mediate resistance to cytotoxic therapy, and ... ...

    Abstract Background: The inhibition of nuclear factor (NF)-kappaB with nontoxic agents is a promising possible treatment approach that may inhibit tumor cell proliferation, counteract the prosurvival pathways that mediate resistance to cytotoxic therapy, and prevent tumor cell metastasis.
    Methods: An initial structure-activity relationship study of the NF-kappaB inhibitory activity of acetophenone-type compounds using electrophoretic mobility shift assay and Western blot analysis is presented. An in vitro cell invasion assay using DA3 cells, a murine breast cancer cell line, was conducted to model antimetastatic activity.
    Results: The carbonyl moiety is found to be the functional group responsible for inhibition of NF-kappaB, and a novel, more effective agent, 6,7-dihydroxy-3,4-dihydroisoquinoline, is postulated and confirmed. The compounds are characterized as active in the inhibition of both the canonical and noncanonical NF-kappaB signaling pathways. Lastly, 6,7-dihydroxy-3,4-dihydroisoquinoline is discovered to inhibit in vitro invasion in DA3 cells.
    Conclusion: 6,7-Dihydroxy-3,4-dihydroisoquionoline and its derivatives are presented as potential prototypes for a novel series of nontoxic antimetastatic agents that can be used in conjunction with current cancer therapeutic techniques.
    MeSH term(s) Acetophenones/pharmacology ; Animals ; Antineoplastic Agents/pharmacology ; Isoquinolines/chemistry ; Isoquinolines/pharmacology ; Mammary Neoplasms, Animal/metabolism ; Mammary Neoplasms, Animal/pathology ; Mice ; NF-kappa B/antagonists & inhibitors ; NF-kappa B/metabolism ; Neoplasm Invasiveness ; Signal Transduction ; Structure-Activity Relationship ; Tumor Cells, Cultured
    Chemical Substances 6,7-dihydroxy-3,4-dihydroisoquinoline ; Acetophenones ; Antineoplastic Agents ; Isoquinolines ; NF-kappa B
    Language English
    Publishing date 2009
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 6708-8
    ISSN 1421-9794 ; 0009-3157
    ISSN (online) 1421-9794
    ISSN 0009-3157
    DOI 10.1159/000215303
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance.

    Farren, Matthew R / Carlson, Louise M / Netherby, Colleen S / Lindner, Inna / Li, Pui-Kai / Gabrilovich, Dmitry I / Abrams, Scott I / Lee, Kelvin P

    Science signaling

    2014  Volume 7, Issue 313, Page(s) ra16

    Abstract: A major mechanism by which cancers escape control by the immune system is by blocking the differentiation of myeloid cells into dendritic cells (DCs), immunostimulatory cells that activate antitumor T cells. Tumor-dependent activation of signal ... ...

    Abstract A major mechanism by which cancers escape control by the immune system is by blocking the differentiation of myeloid cells into dendritic cells (DCs), immunostimulatory cells that activate antitumor T cells. Tumor-dependent activation of signal transducer and activator of transcription 3 (STAT3) signaling in myeloid progenitor cells is thought to cause this block in their differentiation. In addition, a signaling pathway through protein kinase C βII (PKCβII) is essential for the differentiation of myeloid cells into DCs. We found in humans and mice that breast cancer cells substantially decreased the abundance of PKCβII in myeloid progenitor cells through a mechanism involving the enhanced activation of STAT3 signaling by soluble, tumor-derived factors (TDFs). STAT3 bound to previously undescribed negative regulatory elements within the promoter of PRKCB, which encodes PKCβII. We also found a previously undescribed counter-regulatory mechanism through which the activity of PKCβII inhibited tumor-dependent STAT3 signaling by decreasing the abundance of cell surface receptors, such as cytokine and growth factor receptors, that are activated by TDFs. Together, these data suggest that a previously unrecognized cross-talk mechanism between the STAT3 and PKCβII signaling pathways provides the molecular basis for the tumor-induced blockade in the differentiation of myeloid cells, and suggest that enhancing PKCβII activity may be a therapeutic strategy to alleviate cancer-mediated suppression of the immune system.
    MeSH term(s) Animals ; Breast Neoplasms/genetics ; Breast Neoplasms/immunology ; Breast Neoplasms/metabolism ; Breast Neoplasms/pathology ; Breast Neoplasms/therapy ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Dendritic Cells/pathology ; Female ; Humans ; K562 Cells ; Mammary Neoplasms, Animal/genetics ; Mammary Neoplasms, Animal/immunology ; Mammary Neoplasms, Animal/pathology ; Mammary Neoplasms, Animal/therapy ; Mice ; Mice, Inbred BALB C ; Myeloid Progenitor Cells ; Neoplasm Proteins/genetics ; Neoplasm Proteins/immunology ; Protein Kinase C beta/genetics ; Protein Kinase C beta/immunology ; Protein Kinase C beta/metabolism ; Response Elements/immunology ; STAT3 Transcription Factor/genetics ; STAT3 Transcription Factor/immunology ; STAT3 Transcription Factor/metabolism ; Signal Transduction/genetics ; Signal Transduction/immunology
    Chemical Substances Neoplasm Proteins ; STAT3 Transcription Factor ; STAT3 protein, human ; Stat3 protein, mouse ; PRKCB protein, human (EC 2.7.11.13) ; Protein Kinase C beta (EC 2.7.11.13)
    Language English
    Publishing date 2014-02-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2417226-1
    ISSN 1937-9145 ; 1945-0877
    ISSN (online) 1937-9145
    ISSN 1945-0877
    DOI 10.1126/scisignal.2004656
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A pre-matriculation learning program that enables medical students with low prerequisite scores to succeed.

    Lindner, Inna / Sacks, David / Sheakley, Maria / Seidel, Charles / Wahlig, Bruce C / Rojas, Jose D / Coleman, Mary T

    Medical teacher

    2013  Volume 35, Issue 10, Page(s) 872–873

    MeSH term(s) Achievement ; Education, Medical, Undergraduate/organization & administration ; Educational Measurement ; Humans ; Learning ; Students, Medical
    Language English
    Publishing date 2013-10
    Publishing country England
    Document type Letter
    ZDB-ID 424426-6
    ISSN 1466-187X ; 0142-159X
    ISSN (online) 1466-187X
    ISSN 0142-159X
    DOI 10.3109/0142159X.2013.786812
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: 6,7-Dihydroxy-3,4-Dihydroisoquinoline: A Novel Inhibitor of Nuclear Factor-κB and in vitro Invasion in Murine Mammary Cancer Cells

    Alvarez, Francisco N. / Carlson, Louise M. / Lindner, Inna / Lee, Kelvin P.

    Chemotherapy

    2009  Volume 55, Issue 3, Page(s) 175–182

    Abstract: Background: The inhibition of nuclear factor (NF)-κB with nontoxic agents is a promising possible treatment approach that may inhibit tumor cell proliferation, counteract the prosurvival pathways that mediate resistance to cytotoxic therapy, and prevent ... ...

    Institution Pine Crest School, Ft. Lauderdale, Fla., and Department of Microbiology and Immunology, University of Miami Leonard M. Miller School of Medicine, Miami, Fla., USA
    Abstract Background: The inhibition of nuclear factor (NF)-κB with nontoxic agents is a promising possible treatment approach that may inhibit tumor cell proliferation, counteract the prosurvival pathways that mediate resistance to cytotoxic therapy, and prevent tumor cell metastasis. Methods: An initial structure-activity relationship study of the NF-κB inhibitory activity of acetophenone-type compounds using electrophoretic mobility shift assay and Western blot analysis is presented. An in vitro cell invasion assay using DA3 cells, a murine breast cancer cell line, was conducted to model antimetastatic activity. Results: The carbonyl moiety is found to be the functional group responsible for inhibition of NF-κB, and a novel, more effective agent, 6,7-dihydroxy-3,4-dihydroisoquinoline, is postulated and confirmed. The compounds are characterized as active in the inhibition of both the canonical and noncanonical NF-κB signaling pathways. Lastly, 6,7-dihydroxy-3,4-dihydroisoquinoline is discovered to inhibit in vitro invasion in DA3 cells. Conclusion: 6,7-Dihydroxy-3,4-dihydroisoquionoline and its derivatives are presented as potential prototypes for a novel series of nontoxic antimetastatic agents that can be used in conjunction with current cancer therapeutic techniques.
    Keywords Quantitative structure-activity relationship analysis ; Acetophenones ; Nuclear factor-ĸB ; Metastasis
    Language English
    Publishing date 2009-04-30
    Publisher S. Karger AG
    Publishing place Basel, Switzerland
    Document type Article
    Note Pharmacology
    ZDB-ID 6708-8
    ISSN 1421-9794 ; 0009-3157
    ISSN (online) 1421-9794
    ISSN 0009-3157
    DOI 10.1159/000215303
    Database Karger publisher's database

    More links

    Kategorien

  6. Article: Signal transduction in DC differentiation: winged messengers and Achilles' heel.

    Lindner, Inna / Cejas, Pedro J / Carlson, Louise M / Torruellas, Julie / Plano, Gregory V / Lee, Kelvin P

    Advances in experimental medicine and biology

    2007  Volume 590, Page(s) 1–29

    MeSH term(s) Animals ; Bacterial Proteins/physiology ; Cell Differentiation/drug effects ; Cell Differentiation/physiology ; Cell Lineage ; Cytokines/pharmacology ; Cytokines/physiology ; Dendritic Cells/classification ; Dendritic Cells/cytology ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Hematopoietic Stem Cells/cytology ; Hematopoietic Stem Cells/drug effects ; Humans ; Intracellular Signaling Peptides and Proteins/pharmacology ; Intracellular Signaling Peptides and Proteins/physiology ; Lymphocytes/cytology ; Lymphocytes/drug effects ; Mice ; Mitogen-Activated Protein Kinases/physiology ; Models, Immunological ; Myeloid Cells/cytology ; Myeloid Cells/drug effects ; NF-kappa B/physiology ; Neoplastic Stem Cells/cytology ; Neoplastic Stem Cells/drug effects ; Protein Kinase C/physiology ; Signal Transduction/physiology ; Transcription Factor RelB/physiology ; Yersinia Infections/immunology ; Yersinia pestis/physiology
    Chemical Substances Bacterial Proteins ; Cytokines ; Intracellular Signaling Peptides and Proteins ; NF-kappa B ; RELB protein, human ; Relb protein, mouse ; YopP protein, Yersinia ; Transcription Factor RelB (147337-75-5) ; Protein Kinase C (EC 2.7.11.13) ; Mitogen-Activated Protein Kinases (EC 2.7.11.24)
    Language English
    Publishing date 2007
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2214-8019 ; 0065-2598
    ISSN (online) 2214-8019
    ISSN 0065-2598
    DOI 10.1007/978-0-387-34814-8_1
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article: Protein kinase C blockade inhibits differentiation of myeloid blasts into dendritic cells by calcium ionophore A23187.

    Li, Qian / Ozer, Howard / Lindner, Inna / Lee, Kelvin P / Kharfan-Dabaja, Mohamed A

    International journal of hematology

    2005  Volume 81, Issue 2, Page(s) 131–137

    Abstract: Direct differentiation of myeloid leukemia blasts into antigen-presenting dendritic cells (DCs) for use as cellular vaccines is unique in that identification of tumor-specific antigens may not be necessary because the antigens should already be ... ...

    Abstract Direct differentiation of myeloid leukemia blasts into antigen-presenting dendritic cells (DCs) for use as cellular vaccines is unique in that identification of tumor-specific antigens may not be necessary because the antigens should already be endogenously expressed. We hypothesized that signaling through protein kinase C (PKC) is required for differentiation of HL-60 promyeloblasts into DCs upon stimulation with calcium ionophore A23187. To demonstrate the inhibitory effect of PKC blockade, we pretreated HL-60 myeloid blasts with the protein kinase inhibitor bisindolylmaleimide I (Bis-1) for 24 hours and then treated the cells with calcium ionophore A23187 for an additional 24 hours. Controls consisted of HL-60 blasts treated with A23187, Bis-1 alone, or media. We noted that blasts cultured in media, Bis-1, or Bis-1 then A23187 did not develop the morphologic and phenotypic DC characteristics, up-regulate Rel B, or activate allogeneic T-cells. Our findings suggested that PKC blockade inhibits morphologic, phenotypic, and functional differentiation of HL-60 promyeloblasts into antigen-presenting DCs. Our findings supported the role of PKC as an obligatory pathway for calcium ionophore A23187-induced differentiation of HL-60 myeloblasts into antigen-presenting DCs.
    MeSH term(s) Antigen-Presenting Cells ; Calcimycin/pharmacology ; Cell Differentiation/drug effects ; Dendritic Cells/cytology ; Dendritic Cells/immunology ; HL-60 Cells ; Humans ; Immunotherapy, Adoptive/methods ; Indoles/pharmacology ; Leukemia, Myeloid, Acute ; Leukemia, Promyelocytic, Acute/pathology ; Maleimides/pharmacology ; Protein Kinase C/antagonists & inhibitors ; Protein Kinase C/physiology ; Proto-Oncogene Proteins/genetics ; T-Lymphocytes/immunology ; Transcription Factor RelB ; Transcription Factors/genetics ; Up-Regulation/drug effects
    Chemical Substances Indoles ; Maleimides ; Proto-Oncogene Proteins ; RELB protein, human ; Transcription Factors ; Transcription Factor RelB (147337-75-5) ; Calcimycin (37H9VM9WZL) ; Protein Kinase C (EC 2.7.11.13) ; bisindolylmaleimide I (L79H6N0V6C)
    Language English
    Publishing date 2005-02-23
    Publishing country Japan
    Document type Journal Article
    ZDB-ID 1076875-0
    ISSN 1865-3774 ; 0925-5710 ; 0917-1258
    ISSN (online) 1865-3774
    ISSN 0925-5710 ; 0917-1258
    DOI 10.1532/ijh97.na0405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Modulation of dendritic cell differentiation and function by YopJ of Yersinia pestis.

    Lindner, Inna / Torruellas-Garcia, Julie / Torrvellas-Garcia, Julie / Kolonias, Despina / Carlson, Louise M / Tolba, Khaled A / Plano, Gregory V / Lee, Kelvin P

    European journal of immunology

    2007  Volume 37, Issue 9, Page(s) 2450–2462

    Abstract: Yersinia pestis evades immune responses in part by injecting into host immune cells several effector proteins called Yersinia outer proteins (Yops) that impair cellular function. This has been best characterized in the innate effector cells, but much ... ...

    Abstract Yersinia pestis evades immune responses in part by injecting into host immune cells several effector proteins called Yersinia outer proteins (Yops) that impair cellular function. This has been best characterized in the innate effector cells, but much less so for cells involved in adaptive immune responses. Dendritic cells (DC) sit at the crossroads between innate and adaptive immunity, and can function to initiate or inhibit adaptive immune responses. Although Y. pestis can target and inactivate DC, the mechanism responsible for this remains unclear. We have found that injection of Y. pestis YopJ into DC progenitors disrupts key signal transduction pathways and interferes with DC differentiation and subsequent function. YopJ injection prevents up-regulation of the NF-kappaB transcription factor Rel B and inhibits MAPK/ERK activation--both having key roles in DC differentiation. Furthermore, YopJ injection prevents costimulatory ligand up-regulation, LPS-induced cytokine expression, and yields differentiated DC with diminished capability to induce T cell proliferation and IFN-gamma induction. By modulating DC function through YopJ-mediated disruption of signaling pathways during progenitor to DC differentiation, Yersinia may interfere with the adaptive responses necessary to clear the infection as well as establish a tolerant immune environment that leads to chronic infection/carrier state in the surviving host.
    MeSH term(s) Bacterial Proteins/genetics ; Bacterial Proteins/immunology ; Bacterial Proteins/metabolism ; Cell Differentiation/immunology ; Cell Survival ; Cells, Cultured ; Cytokines/biosynthesis ; Dendritic Cells/cytology ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; Humans ; Ligands ; Lipopolysaccharides/pharmacology ; Recombinant Proteins/genetics ; Recombinant Proteins/immunology ; Recombinant Proteins/metabolism ; T-Lymphocytes/cytology ; T-Lymphocytes/immunology ; Yersinia pestis/classification ; Yersinia pestis/immunology
    Chemical Substances Bacterial Proteins ; Cytokines ; Ligands ; Lipopolysaccharides ; Recombinant Proteins ; YopP protein, Yersinia
    Language English
    Publishing date 2007-09
    Publishing country Germany
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.200635947
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Modulation of dendritic cell differentiation and function by YopJ of Yersinia pestis

    Lindner, Inna / Torrvellas-Garcia, Julie / Kolonias, Despina / Carlson, Louise M / Tolba, Khaled A / Plano, Gregory V / Lee, Kelvin P

    European journal of immunology. 2007 Sept., v. 37, no. 9

    2007  

    Abstract: Yersinia pestis evades immune responses in part by injecting into host immune cells several effector proteins called Yersinia outer proteins (Yops) that impair cellular function. This has been best characterized in the innate effector cells, but much ... ...

    Abstract Yersinia pestis evades immune responses in part by injecting into host immune cells several effector proteins called Yersinia outer proteins (Yops) that impair cellular function. This has been best characterized in the innate effector cells, but much less so for cells involved in adaptive immune responses. Dendritic cells (DC) sit at the crossroads between innate and adaptive immunity, and can function to initiate or inhibit adaptive immune responses. Although Y. pestis can target and inactivate DC, the mechanism responsible for this remains unclear. We have found that injection of Y. pestis YopJ into DC progenitors disrupts key signal transduction pathways and interferes with DC differentiation and subsequent function. YopJ injection prevents up-regulation of the NF-κB transcription factor Rel B and inhibits MAPK/ERK activation - both having key roles in DC differentiation. Furthermore, YopJ injection prevents costimulatory ligand up-regulation, LPS-induced cytokine expression, and yields differentiated DC with diminished capability to induce T cell proliferation and IFN-γ induction. By modulating DC function through YopJ-mediated disruption of signaling pathways during progenitor to DC differentiation, Yersinia may interfere with the adaptive responses necessary to clear the infection as well as establish a tolerant immune environment that leads to chronic infection/carrier state in the surviving host.
    Language English
    Dates of publication 2007-09
    Size p. 2450-2462.
    Publishing place Wiley-VCH Verlag
    Document type Article
    ZDB-ID 120108-6
    ISSN 1521-4141 ; 0014-2980
    ISSN (online) 1521-4141
    ISSN 0014-2980
    DOI 10.1002/eji.200635947
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  10. Article: Regulation of RelB expression during the initiation of dendritic cell differentiation.

    Cejas, Pedro J / Carlson, Louise M / Kolonias, Despina / Zhang, Jian / Lindner, Inna / Billadeau, Daniel D / Boise, Lawrence H / Lee, Kelvin P

    Molecular and cellular biology

    2005  Volume 25, Issue 17, Page(s) 7900–7916

    Abstract: The transcription factor RelB is required for proper development and function of dendritic cells (DCs), and its expression is upregulated early during differentiation from a variety of progenitors. We explored this mechanism of upregulation in the KG1 ... ...

    Abstract The transcription factor RelB is required for proper development and function of dendritic cells (DCs), and its expression is upregulated early during differentiation from a variety of progenitors. We explored this mechanism of upregulation in the KG1 cell line model of a DC progenitor and in the differentiation-resistant KG1a subline. RelB expression is relatively higher in untreated KG1a cells but is upregulated only during differentiation of KG1 by an early enhancement of transcriptional elongation, followed by an increase in transcription initiation. Restoration of protein kinase CbetaII (PKCbetaII) expression in KG1a cells allows them to differentiate into DCs. We show that PKCbetaII also downregulated constitutive expression of NF-kappaB in KG1a-transfected cells and restores the upregulation of RelB during differentiation by increased transcriptional initiation and elongation. The two mechanisms are independent and sensitive to PKC signaling levels. Conversely, RelB upregulation was inhibited in primary human monocytes where PKCbetaII expression was knocked down by small interfering RNA targeting. Altogether, the data show that RelB expression during DC differentiation is controlled by PKCbetaII-mediated regulation of transcriptional initiation and elongation.
    MeSH term(s) Cell Differentiation ; Cells, Cultured ; Dendritic Cells/cytology ; Dendritic Cells/metabolism ; Gene Expression Regulation/drug effects ; Gene Expression Regulation/genetics ; Humans ; Promoter Regions, Genetic/genetics ; Protein Kinase C/genetics ; Protein Kinase C/metabolism ; Protein Kinase C beta ; Proto-Oncogene Proteins/genetics ; Proto-Oncogene Proteins/metabolism ; RNA Stability ; RNA, Small Interfering/genetics ; Tetradecanoylphorbol Acetate/pharmacology ; Transcription Factor RelB ; Transcription Factors/genetics ; Transcription Factors/metabolism ; Transcription, Genetic/drug effects ; Transcription, Genetic/genetics
    Chemical Substances Proto-Oncogene Proteins ; RELB protein, human ; RNA, Small Interfering ; Transcription Factors ; Transcription Factor RelB (147337-75-5) ; Protein Kinase C (EC 2.7.11.13) ; Protein Kinase C beta (EC 2.7.11.13) ; Tetradecanoylphorbol Acetate (NI40JAQ945)
    Language English
    Publishing date 2005-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 779397-2
    ISSN 1098-5549 ; 0270-7306
    ISSN (online) 1098-5549
    ISSN 0270-7306
    DOI 10.1128/MCB.25.17.7900-7916.2005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top